Menu Search
Equities

ALT5 Sigma Corp

5AR1:BER

ALT5 Sigma Corp

Actions
  • Price (EUR)1.80
  • Today's Change0.00 / 0.00%
  • Shares traded15.00
  • 1 Year change+99.78%
  • Beta--
Data delayed at least 15 minutes, as of Jul 25 2024 09:18 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ALT5 Sigma Corporation, formerly JanOne Inc., is a multidisciplinary organization with a focus on healthcare and fintech. Through its fintech activities, it provides blockchain-powered technologies to enable a migration to a new global financial paradigm for the trading, clearing, settlement, payment, and custodianship of digital instruments. Through its fintech subsidiaries, it offers two main platforms to its customers: ALT5 Pay and ALT5 Prime. ALT5 Pay is a cryptocurrency payment gateway that enables registered and approved global merchants to accept and make cryptocurrency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Through its biotech activities, it is developing solutions intended to help end the opioid crisis.

  • Revenue in USD (TTM)0.00
  • Net income in USD-18.58m
  • Incorporated2018
  • Employees5.00
  • Location
    ALT5 Sigma Corp325 E Warm Springs Rd Ste 102LAS VEGAS 89119-4240United StatesUSA
  • Phone+1 (702) 997-5968
  • Websitehttps://janone.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.